Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Type I Interferons Direct Gammaherpesvirus Host Colonization.

Tan CS, Lawler C, May JS, Belz GT, Stevenson PG.

PLoS Pathog. 2016 May 25;12(5):e1005654. doi: 10.1371/journal.ppat.1005654. eCollection 2016 May.

2.

Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination.

Frederico B, Chao B, Lawler C, May JS, Stevenson PG.

J Gen Virol. 2015 Aug;96(8):2314-27. doi: 10.1099/vir.0.000140. Epub 2015 Apr 14.

3.

Rhadinovirus host entry by co-operative infection.

Lawler C, Milho R, May JS, Stevenson PG.

PLoS Pathog. 2015 Mar 19;11(3):e1004761. doi: 10.1371/journal.ppat.1004761. eCollection 2015 Mar.

4.

Cochlear Implantation in Ménière's Disease.

Fife TA, Lewis MP, May JS, Oliver ER.

JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):535-9. doi: 10.1001/jamaoto.2014.550.

PMID:
24789018
5.

A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread.

Frederico B, Chao B, May JS, Belz GT, Stevenson PG.

Cell Host Microbe. 2014 Apr 9;15(4):457-70. doi: 10.1016/j.chom.2014.03.010.

6.

BAFF receptor deficiency limits gammaherpesvirus infection.

Frederico B, May JS, Efstathiou S, Stevenson PG.

J Virol. 2014 Apr;88(8):3965-75. doi: 10.1128/JVI.03497-13. Epub 2014 Feb 5.

7.

Langerhans cell histiocytosis: temporal bone invasion in an adult.

Alexander RL, Worthen ML, Pang CS, May JS.

Ear Nose Throat J. 2013 Oct-Nov;92(10-11):496, 498. No abstract available.

PMID:
24170459
8.

Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry.

Shivkumar M, Milho R, May JS, Nicoll MP, Efstathiou S, Stevenson PG.

J Virol. 2013 Oct;87(19):10477-88. doi: 10.1128/JVI.01748-13. Epub 2013 Jul 31.

9.

Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells.

Glauser DL, Milho R, Frederico B, May JS, Kratz AS, Gillet L, Stevenson PG.

J Virol. 2013 Oct;87(19):10828-42. doi: 10.1128/JVI.00709-13. Epub 2013 Jul 31.

10.

The neuropsychological contributors to psychopathic personality traits in adolescence.

May JS, Beaver KM.

Int J Offender Ther Comp Criminol. 2014 Mar;58(3):265-85. doi: 10.1177/0306624X12469861. Epub 2012 Dec 30.

PMID:
23277225
11.

Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4.

Frederico B, Milho R, May JS, Gillet L, Stevenson PG.

PLoS Pathog. 2012 Sep;8(9):e1002935. doi: 10.1371/journal.ppat.1002935. Epub 2012 Sep 20.

12.

Murid herpesvirus-4 exploits dendritic cells to infect B cells.

Gaspar M, May JS, Sukla S, Frederico B, Gill MB, Smith CM, Belz GT, Stevenson PG.

PLoS Pathog. 2011 Nov;7(11):e1002346. doi: 10.1371/journal.ppat.1002346. Epub 2011 Nov 10.

13.

In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit.

Milho R, Gill MB, May JS, Colaco S, Stevenson PG.

J Gen Virol. 2011 Jul;92(Pt 7):1550-60. doi: 10.1099/vir.0.031542-0. Epub 2011 Apr 6.

14.

Interference with dendritic cell populations limits early antigen presentation in chronic γ-herpesvirus-68 infection.

Mount AM, Masson F, Kupresanin F, Smith CM, May JS, van Rooijen N, Stevenson PG, Belz GT.

J Immunol. 2010 Sep 15;185(6):3669-76. doi: 10.4049/jimmunol.1001079. Epub 2010 Aug 18.

15.

Important role for the murid herpesvirus 4 ribonucleotide reductase large subunit in host colonization via the respiratory tract.

Gill MB, May JS, Colaco S, Stevenson PG.

J Virol. 2010 Oct;84(20):10937-42. doi: 10.1128/JVI.00828-10. Epub 2010 Jul 28.

16.

Vaccination against a hit-and-run viral cancer.

Stevenson PG, May JS, Connor V, Efstathiou S.

J Gen Virol. 2010 Sep;91(Pt 9):2176-85. doi: 10.1099/vir.0.023507-0. Epub 2010 Jun 23.

17.

An in vitro system for studying murid herpesvirus-4 latency and reactivation.

May JS, Bennett NJ, Stevenson PG.

PLoS One. 2010 Jun 11;5(6):e11080. doi: 10.1371/journal.pone.0011080.

18.

Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization.

May JS, Stevenson PG.

J Gen Virol. 2010 Oct;91(Pt 10):2542-52. doi: 10.1099/vir.0.023085-0. Epub 2010 Jun 2.

19.

Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization.

Gill MB, Wright DE, Smith CM, May JS, Stevenson PG.

J Gen Virol. 2009 Jun;90(Pt 6):1461-70. doi: 10.1099/vir.0.010603-0. Epub 2009 Mar 4.

20.

Glycoprotein L sets the neutralization profile of murid herpesvirus 4.

Gillet L, Alenquer M, Glauser DL, Colaco S, May JS, Stevenson PG.

J Gen Virol. 2009 May;90(Pt 5):1202-14. doi: 10.1099/vir.0.008755-0. Epub 2009 Mar 4.

21.

In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.

Gillet L, May JS, Stevenson PG.

J Gen Virol. 2009 Mar;90(Pt 3):602-13. doi: 10.1099/vir.0.005785-0.

22.

In vivo imaging of murid herpesvirus-4 infection.

Milho R, Smith CM, Marques S, Alenquer M, May JS, Gillet L, Gaspar M, Efstathiou S, Simas JP, Stevenson PG.

J Gen Virol. 2009 Jan;90(Pt 1):21-32. doi: 10.1099/vir.0.006569-0.

23.

Multiple functions for ORF75c in murid herpesvirus-4 infection.

Gaspar M, Gill MB, Lösing JB, May JS, Stevenson PG.

PLoS One. 2008 Jul 23;3(7):e2781. doi: 10.1371/journal.pone.0002781.

24.

An essential role for the proximal but not the distal cytoplasmic tail of glycoprotein M in murid herpesvirus 4 infection.

May JS, Smith CM, Gill MB, Stevenson PG.

PLoS One. 2008 May 7;3(5):e2131. doi: 10.1371/journal.pone.0002131.

25.

A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread.

Gill MB, Edgar R, May JS, Stevenson PG.

PLoS One. 2008 Mar 19;3(3):e1808. doi: 10.1371/journal.pone.0001808.

26.

Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells.

Smith CM, Gill MB, May JS, Stevenson PG.

PLoS One. 2007 Oct 17;2(10):e1048.

27.

Post-exposure vaccination improves gammaherpesvirus neutralization.

Gillet L, May JS, Stevenson PG.

PLoS One. 2007 Sep 19;2(9):e899.

28.

The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization.

Gillet L, May JS, Colaco S, Stevenson PG.

PLoS One. 2007 Aug 8;2(8):e705.

29.

CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo.

Smith CM, Rosa GT, May JS, Bennett NJ, Mount AM, Belz GT, Stevenson PG.

Eur J Immunol. 2006 Dec;36(12):3186-97.

30.

Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H.

Gillet L, May JS, Colaco S, Stevenson PG.

J Virol. 2007 Jan;81(1):280-91. Epub 2006 Oct 18.

31.

Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies.

Gill MB, Gillet L, Colaco S, May JS, de Lima BD, Stevenson PG.

J Gen Virol. 2006 Jun;87(Pt 6):1465-75.

PMID:
16690911
32.
33.

The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread.

May JS, Walker J, Colaco S, Stevenson PG.

J Virol. 2005 Apr;79(8):5059-68.

34.

Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein.

May JS, Coleman HM, Boname JM, Stevenson PG.

J Gen Virol. 2005 Apr;86(Pt 4):919-28.

PMID:
15784886
35.

Gamma-herpesvirus latency requires T cell evasion during episome maintenance.

Bennett NJ, May JS, Stevenson PG.

PLoS Biol. 2005 Apr;3(4):e120. Epub 2005 Mar 22.

36.
37.
38.

Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo.

de Lima BD, May JS, Marques S, Simas JP, Stevenson PG.

J Gen Virol. 2005 Jan;86(Pt 1):31-40.

PMID:
15604429
39.
40.

Characterization of murine gammaherpesvirus 68 glycoprotein B.

Lopes FB, Colaco S, May JS, Stevenson PG.

J Virol. 2004 Dec;78(23):13370-5.

41.
42.

Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68.

May JS, Coleman HM, Smillie B, Efstathiou S, Stevenson PG.

J Gen Virol. 2004 Jan;85(Pt 1):137-46.

PMID:
14718628
43.

Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.

Boname JM, Coleman HM, May JS, Stevenson PG.

J Gen Virol. 2004 Jan;85(Pt 1):131-5.

PMID:
14718627
44.

K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.

Stevenson PG, May JS, Smith XG, Marques S, Adler H, Koszinowski UH, Simas JP, Efstathiou S.

Nat Immunol. 2002 Aug;3(8):733-40. Epub 2002 Jul 8.

PMID:
12101398
45.

Proteasomal degradation of retinoblastoma-related p130 during adipocyte differentiation.

Prince AM, May JS, Burton GR, Lyle RE, McGehee RE Jr.

Biochem Biophys Res Commun. 2002 Jan 25;290(3):1066-71.

PMID:
11798183
46.

Antisense suppression of p107 inhibits 3T3-L1 adipocyte differentiation.

May JS, Prince AM, Lyle RE, McGehee RE Jr.

Biochem Biophys Res Commun. 2001 May 18;283(4):837-42.

PMID:
11350060
47.

Spontaneous cerebrospinal fluid otorrhea from defects of the temporal bone: a rare entity?

May JS, Mikus JL, Matthews BL, Browne JD.

Am J Otol. 1995 Nov;16(6):765-71.

PMID:
8572139
48.

Aberrant internal carotid artery.

Cole RD, May JS.

South Med J. 1994 Dec;87(12):1277-80.

PMID:
7973930
49.

Leiomyosarcoma of the skull base-a diagnostic challenge.

May JS, Wiestler OD, Fisch U.

Skull Base Surg. 1992;2(2):103-11.

50.

Platysma myocutaneous flap: caveats reexamined.

McGuirt WF, Matthews BL, Brody JA, May JS.

Laryngoscope. 1991 Nov;101(11):1238-44. Review. No abstract available.

PMID:
1943427

Supplemental Content

Support Center